Physician profile
Joy Spitale
NPI 1356634968
$937.16
in general payments reported to CMS, 2019-2025
12 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.23 · 2022: $20.38 · 2023: $274 · 2024: $289 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $335.54 | 2023-2025 | |
| Medtronic, INC. | $254.51 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| Lexicon Pharmaceuticals, INC. | $105.80 | 2024 | Inpefa |
| Baxter Healthcare | $71.56 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $49.05 | 2025 | Cardiva Vascade 6/7f Vcs |
| Abbott Laboratories | $21.40 | 2023 | Mitraclip |
| Novo Nordisk INC | $21.39 | 2024 | Wegovy |
| Boston Scientific Corporation | $20.66 | 2023 | Watchman |
| Silk Road Medical, INC. | $15.49 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Pfizer INC. | $15.19 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.39 | 2025 | Lifevest |
| Philips North America LLC | $13.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Spitale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.